Overview

Stem Cell Mobilization by G-CSF to Treat Severe Peripheral Artery Disease

Status:
Completed
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
This study is designed to test the use of G-CSF in peripheral vascular disease. The investigators hypothesize that mobilization of angiogenic cells into the blood by granulocyte colony stimulating factor (G-CSF) may stimulate the formation of new blood vessels and result in a sustained improvement in blood flow in patients with severe peripheral arterial disease.
Phase:
Early Phase 1
Details
Lead Sponsor:
Washington University School of Medicine
Treatments:
Aspirin
Clopidogrel
Lenograstim